SE9704693D0 - Method of the prophylactic treatment of mastitis - Google Patents

Method of the prophylactic treatment of mastitis

Info

Publication number
SE9704693D0
SE9704693D0 SE9704693A SE9704693A SE9704693D0 SE 9704693 D0 SE9704693 D0 SE 9704693D0 SE 9704693 A SE9704693 A SE 9704693A SE 9704693 A SE9704693 A SE 9704693A SE 9704693 D0 SE9704693 D0 SE 9704693D0
Authority
SE
Sweden
Prior art keywords
mastitis
prophylactic treatment
mothers
astaxanthin
human
Prior art date
Application number
SE9704693A
Other languages
English (en)
Other versions
SE511237C2 (sv
SE9704693L (sv
Inventor
Aake Lignell
Johan Inborr
Original Assignee
Astacarotene Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astacarotene Ab filed Critical Astacarotene Ab
Priority to SE9704693A priority Critical patent/SE511237C2/sv
Publication of SE9704693D0 publication Critical patent/SE9704693D0/sv
Priority to US09/589,594 priority patent/US6335015B1/en
Priority to PCT/SE1998/002279 priority patent/WO1999030701A1/en
Priority to AT98963702T priority patent/ATE239457T1/de
Priority to EP98963702A priority patent/EP1049460B1/en
Priority to AU18972/99A priority patent/AU743198B2/en
Priority to JP2000538684A priority patent/JP2002508318A/ja
Priority to CA002314170A priority patent/CA2314170C/en
Priority to NZ504801A priority patent/NZ504801A/en
Priority to DE69814467T priority patent/DE69814467D1/de
Priority to ARP980106418A priority patent/AR017877A1/es
Publication of SE9704693L publication Critical patent/SE9704693L/sv
Publication of SE511237C2 publication Critical patent/SE511237C2/sv
Priority to NO20003042A priority patent/NO327301B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
SE9704693A 1997-12-16 1997-12-16 Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor SE511237C2 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE9704693A SE511237C2 (sv) 1997-12-16 1997-12-16 Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor
DE69814467T DE69814467D1 (de) 1997-12-16 1998-12-10 Verfahren zur prophylaktischen behandlung von mastitis
JP2000538684A JP2002508318A (ja) 1997-12-16 1998-12-10 乳腺炎の予防処置法
PCT/SE1998/002279 WO1999030701A1 (en) 1997-12-16 1998-12-10 Method of the prophylactic treatment of mastitis
AT98963702T ATE239457T1 (de) 1997-12-16 1998-12-10 Verfahren zur prophylaktischen behandlung von mastitis
EP98963702A EP1049460B1 (en) 1997-12-16 1998-12-10 Method for the prophylactic treatment of mastitis
AU18972/99A AU743198B2 (en) 1997-12-16 1998-12-10 Method of the prophylactic treatment of mastitis
US09/589,594 US6335015B1 (en) 1997-12-16 1998-12-10 Method of the prophylactic treatment of mastitis
CA002314170A CA2314170C (en) 1997-12-16 1998-12-10 Method of the prophylactic treatment of mastitis
NZ504801A NZ504801A (en) 1997-12-16 1998-12-10 A medicament containing one type of xanthophylis for the prophylactic treatment of mastitis
ARP980106418A AR017877A1 (es) 1997-12-16 1998-12-16 Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodo
NO20003042A NO327301B1 (no) 1997-12-16 2000-06-14 Anvendelse av astaxanthin for fremstilling av et medikament til behandling av mastitt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704693A SE511237C2 (sv) 1997-12-16 1997-12-16 Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor

Publications (3)

Publication Number Publication Date
SE9704693D0 true SE9704693D0 (sv) 1997-12-16
SE9704693L SE9704693L (sv) 1999-06-17
SE511237C2 SE511237C2 (sv) 1999-08-30

Family

ID=20409414

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9704693A SE511237C2 (sv) 1997-12-16 1997-12-16 Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor

Country Status (12)

Country Link
US (1) US6335015B1 (sv)
EP (1) EP1049460B1 (sv)
JP (1) JP2002508318A (sv)
AR (1) AR017877A1 (sv)
AT (1) ATE239457T1 (sv)
AU (1) AU743198B2 (sv)
CA (1) CA2314170C (sv)
DE (1) DE69814467D1 (sv)
NO (1) NO327301B1 (sv)
NZ (1) NZ504801A (sv)
SE (1) SE511237C2 (sv)
WO (1) WO1999030701A1 (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903336D0 (sv) * 1999-09-17 1999-09-17 Astacarotene Ab DNA construct and its use
SE9903619D0 (sv) * 1999-10-07 1999-10-07 Astacarotene Ab Use and method of treatment
US7320997B2 (en) 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US7723327B2 (en) 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US7763649B2 (en) 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7145025B2 (en) 2002-07-29 2006-12-05 Hawaii Biotech, Inc. Structural carotenoid analogs for the inhibition and amelioration of disease
US7345091B2 (en) 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
EP1750723A1 (en) * 2004-04-14 2007-02-14 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
BRPI0516202A (pt) 2004-09-28 2008-08-26 Chemaphor Inc produto para alimentação de um animal, uso, kit e método de preparação deste produto
US20060167319A1 (en) * 2004-10-01 2006-07-27 Lockwood Samuel F Methods for the synthesis of unsaturated ketone intermediates useful for the synthesis of carotenoids
JP2011500733A (ja) 2007-10-26 2011-01-06 ケマファー インコーポレーテッド 免疫応答を増強するための組成物および方法
WO2010124392A1 (en) * 2009-04-30 2010-11-04 Chemaphor Inc. Methods, compositions, and kits for the treatment of inflammatory conditions
EP2424512B1 (en) 2009-04-30 2020-06-03 Avivagen Inc. Methods and compositions for improving the health of animals
KR20220142505A (ko) * 2020-02-18 2022-10-21 아비바젠 인코포레이티드. 포유동물용 보충 동물 사료

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2619491B2 (ja) 1988-08-11 1997-06-11 サントリー株式会社 アスタキサンチン含有組成物
CA2210957A1 (en) 1995-02-03 1996-08-08 Basf Aktiengesellschaft The use of carotenoids for producing drugs for the treatment of dermatoses
JPH09124470A (ja) * 1995-10-26 1997-05-13 Suntory Ltd 抗ストレス組成物
SE506191C2 (sv) 1996-03-27 1997-11-17 Astacarotene Ab Medel och sätt för att öka produktionen av/hos däggdjur

Also Published As

Publication number Publication date
CA2314170C (en) 2008-01-29
CA2314170A1 (en) 1999-06-24
US6335015B1 (en) 2002-01-01
AR017877A1 (es) 2001-10-24
NO20003042D0 (no) 2000-06-14
WO1999030701A1 (en) 1999-06-24
NZ504801A (en) 2002-05-31
JP2002508318A (ja) 2002-03-19
NO20003042L (no) 2000-06-14
EP1049460A1 (en) 2000-11-08
AU1897299A (en) 1999-07-05
AU743198B2 (en) 2002-01-24
SE511237C2 (sv) 1999-08-30
DE69814467D1 (de) 2003-06-12
EP1049460B1 (en) 2003-05-07
ATE239457T1 (de) 2003-05-15
SE9704693L (sv) 1999-06-17
NO327301B1 (no) 2009-06-02

Similar Documents

Publication Publication Date Title
SE9704693D0 (sv) Method of the prophylactic treatment of mastitis
DE69815677D1 (de) Orale zubereitung zur prophylaktischen/therapeutischen behandlung von helicobactor sp. infektionen
ES2061772T3 (es) Inhalante aerosol que comprende un ester de retinol y/o de acido retinico.
AU7264187A (en) Formulations containing unsaturated fatty acids for the synthesis of prostaglandins and hydroxy-fatty acids in biological systems
ES2160821T3 (es) Uso de una composicion que comprende amoxicilina y acido clavulanico para la produccion de un medicamento para el tratamiento de infecciones bacterianas en pacientes pediatricos.
SE9704590D0 (sv) Method of increasing the production and improving the quality of semen
SE9704584D0 (sv) Formation of fatty acid
PT81372B (pt) Processo para a preparacao de glicopeptidos e de composicoes anti-bacterianas que os contem
SE9803541D0 (sv) Treatment of dyspepsia
CA2037779A1 (en) Antibiotic ge 2270 factors b1, b2, c1, c2, d1, d2, e and t
SE9704737D0 (sv) Immunoglobulin-rich milk, production and use thereof
ES8205190A1 (es) Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10-14-hexadecapentaenoico.
KR101623553B1 (ko) 여드름 치료, 예방 또는 개선에 유효한 클로린 e6
ATE260671T1 (de) Zubereitungen auf basis von padina algen oder ihrer extrakten, und ihre pharmazeutische, nährungsmittel oder für die kultur von mollusken oder arthropoden kulturverwendungen
DE69317058D1 (de) Die antibiotika ge 37468 a, b und c
AU2001278375A1 (en) Composition for pharmaceutical and cosmetic products
CN105519815A (zh) 一种用于提高鸡免疫力的饲料添加剂
NO157426C (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser ved dyrking av mikroorganismer.
DE3473457D1 (en) A new compound, fr-900451, production and use thereof
RU94031387A (ru) Способ повышения иммунного статуса цыплят путем сочетанного применения пробиотика и иммуномодулятора
CN105707509A (zh) 一种用于防治草鱼烂腮病的饲料添加剂
KR920005982A (ko) 피부질환용 약제조성물 및 그 제법
GR1002969B (el) Φαρμακευτικο παρασκευασμα βασιζομενο σε αιωρημα εμβρυικων κυτταρων με δραση ανοσοποιητικης υποκαταστασης και μεθοδος θεραπειας του συνδρομου της επικτητης μολυνσης ανοσοποιητικης ανεπαρκειας (hiv) με τη χρηση αυτου του παρασκευασματος.
IT1238210B (it) Esteri del cefamandolo nafato, procedimento per la loro preparazione erelative composizioni farmaceutiche.
JPS53127890A (en) Preparation of l-arginosuccinic acid by fermentation

Legal Events

Date Code Title Description
NUG Patent has lapsed